Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
Journal of Breast Cancer|June 15, 2021
Programmed Death Ligand 1 Immunohistochemistry in Triple-Negative Breast Cancer: Evaluation of Inter-Pathologist Concordance and Inter-Assay VariabilitySoomin Ahn, Ji Won Woo, Hyojin Kim, et al.Functional & Integrative Genomics|July 17, 2021
RNA-sequencing identification and validation of genes differentially expressed in high-risk adenoma, advanced colorectal cancer, and normal controlsNamjoo Kim, Jeong-An Gim, Beom Jae Lee, et al.The New England Journal of Medicine|December 14, 2004
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancerSoonmyung Paik, Steven Shak, Gong Tang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 10, 2012
Mutation profiling and microsatellite instability in stage II and III colon cancer: an assessment of their prognostic and oxaliplatin predictive valuePatrick G Gavin, Linda H Colangelo, Debora Fumagalli, et al.Journal of Pathology and Translational Medicine|February 23, 2026
Prevalence of HER2-ultralow breast cancer in South Korea: a multicenter study by reassessment of HER2-zero casesMin Chong Kim, Eun Yoon Cho, Hee Jin Lee, et al.Breast Cancer Research and Treatment|February 20, 2013
Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005)Edith A Perez, Michael F Press, Amylou C Dueck, et al.Theranostics|January 4, 2021
Extra-domain B of fibronectin as an alternative target for drug delivery and a cancer diagnostic and prognostic biomarker for malignant gliomaPhei Er Saw, Xiaoding Xu, Bo Ram Kang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2020
Development and Validation of a Next-Generation Sequencing-Based Multigene Assay to Predict the Prognosis of Estrogen Receptor-Positive, HER2-Negative Breast CancerHan-Byoel Lee, Sae Byul Lee, Minsu Kim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2011
Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor-positive breast cancerChungyeul Kim, Gong Tang, Katherine L Pogue-Geile, et al.Science (New York, N.Y.)|January 8, 2026
IDH-mutant gliomas arise from glial progenitor cells harboring the initial driver mutationJung Won Park, Jiehoon Kwak, Keon-Woo Kim, et al.Pageof 6